superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2023-12-31
- Valid until
- 2024-12-31
- Published
- 2024-02-23
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 28,754,000,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "Gilead Sciences revenue: 27,116,000,000 United States dollar", as of 2023-12-31 (until 2024-12-31). Claim clm_ABFE2CB3CF48, https://asof.is/claim/clm_ABFE2CB3CF48, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/882095/000088209524000007/0000882095-24-000007-index.htm.
APA
AsOf. (2023). Gilead Sciences revenue: 27,116,000,000 United States dollar (as of 2023-12-31 (until 2024-12-31)) [Record clm_ABFE2CB3CF48]. Retrieved November 8, 2026, from https://asof.is/claim/clm_ABFE2CB3CF48 (source: https://www.sec.gov/Archives/edgar/data/882095/000088209524000007/0000882095-24-000007-index.htm)
BibTeX
@misc{asof_clm_ABFE2CB3CF48,
author = {AsOf},
title = {Gilead Sciences revenue: 27,116,000,000 United States dollar},
year = {2023},
howpublished = {\url{https://asof.is/claim/clm_ABFE2CB3CF48}},
note = {Claim clm\_ABFE2CB3CF48, as of 2023-12-31 (until 2024-12-31); source: https://www.sec.gov/Archives/edgar/data/882095/000088209524000007/0000882095-24-000007-index.htm},
urldate = {2026-11-08}
}Supersedes
On the record
/claim/clm_ABFE2CB3CF48.md/v1/claims/clm_ABFE2CB3CF48submit a correction